Filtered By:
Specialty: Cancer & Oncology

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 61 results found since Jan 2013.

Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia
This study demonstrates that a large proportion (54.1%) of HSCT survivors is using one or more form of complementary and alternative medical (CAM) therapies. Given the potential benefits demonstrated by small studies of particular CAM therapies in this patient group, as well as clearly documented therapies with no benefit or even toxicity, this result shows there is a large unmet need for additional studies to ascertain efficacy and safety of CAM therapies in this growing population.
Source: Cancer Medicine - October 26, 2016 Category: Cancer & Oncology Authors: Julian Lindsay, Masrura Kabir, Nicole Gilroy, Gemma Dyer, Lisa Brice, John Moore, Matthew Greenwood, Mark Hertzberg, David Gottlieb, Stephen R. Larsen, Megan Hogg, Louisa Brown, Gillian Huang, Jeff Tan, Christopher Ward, Ian Kerridge Tags: Original Research Source Type: research

Stop vets offering homeopathy – placebo doesn’t work for pets
Homeopathy has no effect beyond placebo and is pointless in animal medicine, so let's end its use by those vets who still offer it, says Danny Chambers
Source: New Scientist - Cancer - June 23, 2016 Category: Cancer & Oncology Source Type: research

Use of complementary and alternative medicine by pediatric oncology patients during palliative care
Conclusions The study provides information about usage of CAM in children suffering from cancer during the palliative phase of the disease. Further research is required to investigate benefits, potential adverse effects, and the potential efficacy of CAM in this population.
Source: Supportive Care in Cancer - May 25, 2016 Category: Cancer & Oncology Source Type: research

A76 * Homeopathy in the treatment of menopausal symptoms in patients with early breast cancer
Source: Annals of Oncology - October 26, 2015 Category: Cancer & Oncology Authors: Desiderio, F., Rudnas, B., Panzini, I., Pini, E., Gianni, L., Tamburini, E., Ravaioli, A., Drudi, G., Tassinari, D. Tags: Session A. Breast cancer Source Type: research

A French survey on the resort of oral alternative complementary medicines used in children with cancer.
CONCLUSIONS: The use of oral CAM in this survey was common. For most parents, this use was effective and appreciated because they generated fewer side effects than conventional treatments. However, doctors were not systematically informed of this use. This is problematic because some CAM such as herbal supplements could potentially cause interactions with cancer treatments. More information about CAM is necessary in pediatric onco-hematology. PMID: 26387822 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - September 17, 2015 Category: Cancer & Oncology Authors: Philibert C, Hoegy D, Philippe M, Marec-Bérard P, Bleyzac N Tags: Bull Cancer Source Type: research

Is There a Role for Homeopathy in Cancer Care? Questions and Challenges
Abstract Patients with cancer commonly use complementary and integrative medicine, including homeopathy. Homeopathy has grown in popularity with the public but is viewed with skepticism by medical academia and is still excluded from conventionally prescribed treatments. In recent years, homeopathy has been used in cancer care in Europe and other countries worldwide. This use raised the question if there is any benefit in utilizing this type of care with cancer patients. The purpose of this manuscript is to explore the evidence related to the benefit of homeopathy in cancer care. Limited research has suggested tha...
Source: Current Oncology Reports - July 26, 2015 Category: Cancer & Oncology Source Type: research

Abstract P2-12-03: The financial costs of metastatic breast cancer and the decisions patients make to cope with costs: Findings from the Cancer Experience Registry
Conclusion: MBC places a significant financial burden on patients, which can result in patients taking measures that can significantly impact their quality of life. Future implications for research include the development and evaluation of interventions designed to enhance doctor-patient communication and support (e.g., financial counseling) to ensure that the financial cost of MBC does not negatively impact the patient’s quality of life, course of cancer care, and health outcomes. Citation Format: Joanne Buzaglo, Anne Morris, Melissa Miller, Allison Harvey, Mitch Golant. The financial costs of metastatic breast cancer a...
Source: Cancer Research - April 30, 2015 Category: Cancer & Oncology Authors: Buzaglo, J., Morris, A., Miller, M., Harvey, A., Golant, M. Tags: Poster Session Abstracts Source Type: research

Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe
Conclusions Mapping of the centres across Europe is an essential step in the process of creating a European network of centres, experts and professionals constantly engaged in the field of integrative oncology, in order to increase, share and disseminate the knowledge in this field and provide evidence-based practice.
Source: Supportive Care in Cancer - December 4, 2014 Category: Cancer & Oncology Source Type: research

Lifestyle, biomechanical, and bioenergetic complementary therapies in pediatric oncology.
Authors: McLean TW, Kemper KJ Abstract After the diagnosis of cancer in a child is made, many families complement conventional medical care with lifestyle changes including diet, exercise, environment, and mind-body therapies. Biomechanical, bioenergetic, and other therapies are also sometimes sought. These include massage, chiropractic, acupuncture/acupressure, therapeutic touch, Reiki, homeopathy, and prayer. Some of these complementary therapies have well-established roles in cancer therapy for children, whereas others are controversial and require more research. PMID: 17022926 [PubMed - indexed for MEDLINE]
Source: Journal of the Society for Integrative Oncology - December 2, 2014 Category: Cancer & Oncology Tags: J Soc Integr Oncol Source Type: research

Homeopathy: promotion versus evidence.
Authors: Ernst E Abstract Homeopathy is a biologically implausible form of treatment. The best clinical evidence available to date fails to support its effectiveness. Nevertheless, it is gaining in popularity. One reason for this is that, at least in the UK, it is being promoted by influential people. PMID: 19442345 [PubMed - indexed for MEDLINE]
Source: Journal of the Society for Integrative Oncology - December 2, 2014 Category: Cancer & Oncology Tags: J Soc Integr Oncol Source Type: research

Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna.
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - April 21, 2014 Category: Cancer & Oncology Source Type: clinical trials

Exploring frontiers: Use of complementary and alternative medicine among patients with early-stage breast cancer.
CONCLUSION: Breast cancer patients are common users of CAM concomitantly to their conventional cancer treatments and should be investigated regarding their current consumption of CAM. Furthermore, they need advice evidence-based data on these treatments and potential interactions with on-going treatments. PMID: 24529905 [PubMed - as supplied by publisher]
Source: Breast - February 12, 2014 Category: Cancer & Oncology Authors: Saghatchian M, Bihan C, Chenailler C, Mazouni C, Dauchy S, Delaloge S Tags: Breast Source Type: research

Differences in use of complementary and alternative medicine between children and adolescents with cancer in Germany: A population based survey
ConclusionsThe high prevalence rates seem to represent the parental or patients needs for additional treatment perceived as successful and devoid of side‐effects. Clinical care and the physician–patient relation would profit from an enhanced understanding of CAM and a greater candidness towards the parental needs. Safety and efficacy – especially of CAM with high prevalence rates – should be studied in rigorous basic and clinical research. Pediatr Blood Cancer © 2013 Wiley Periodicals, Inc.
Source: Pediatric Blood and Cancer - September 13, 2013 Category: Cancer & Oncology Authors: Sven Gottschling, Sascha Meyer, Alfred Längler, Gilbert Scharifi, Friedrich Ebinger, Benjamin Gronwald Tags: Research Article Source Type: research

The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treated With Unconventional Therapies in India
Conclusion. The challenge for submitters rests in their ability to supply sufficient documentation for the NCI BCS Program. The NCI BCS Program represents a unique avenue for the rigorous evaluation of "best cases" to identify complementary and alternative medicine modalities that are promising for prospective preclinical evaluation or prospective research.
Source: Integrative Cancer Therapies - August 27, 2013 Category: Cancer & Oncology Authors: Olaku, O., Zia, F., Santana, J. M., White, J. D. Tags: Articles Source Type: research